Johan Kullingsjö

In vivo pharmacology of the dopaminergic stabilizer pridopidine

Henrik Pontén, Johan Kullingsjö, Sören Lagerkvist et al. · European Journal of Pharmacology · 2010 · 60 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington's disease

Yvonne K. Urbach, Kerstin Raber, Fabio Canneva et al. · Journal of Neuroscience Methods · 2014 · 45 citations

Life Sciences, Bioinformatics, Biomedical Informatics +12

Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease

Clas Sonesson, Peder Svensson, Joakim Tedroff et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 23 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease

M Esmaeilzadeh, Johan Kullingsjö, Henrik Ullman et al. · Clinical Neuropharmacology · 2011 · 17 citations

Life Sciences, Neurology, Neuroscience +17

The dopaminergic stabilizer pridopidine decreases expression of l-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model

Henrik Pontén, Johan Kullingsjö, Clas Sonesson et al. · European Journal of Pharmacology · 2012 · 15 citations

Life Sciences, Neuroscience, Pharmacology +16